The primary endpoint for efficacy is the first episode during the first year in a study child of a culture-confirmed influenza-illness, caused by community-acquired subtypes. [clinicaltrials_resource:870996c0e418537acd1ac135363e5ac0]
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
The primary endpoint for efficacy is the first episode during the first year in a study child of a culture-confirmed influenza-illness, caused by community-acquired subtypes. [clinicaltrials_resource:870996c0e418537acd1ac135363e5ac0]
Bio2RDF identifier
870996c0e418537acd1ac135363e5ac0
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:870996c0e418537acd1ac135363e5ac0
measure [clinicaltrials_vocabulary:measure]
The primary endpoint for effic ...... y community-acquired subtypes.
identifier
clinicaltrials_resource:870996c0e418537acd1ac135363e5ac0
title
The primary endpoint for effic ...... y community-acquired subtypes.
@en
type
label
The primary endpoint for effic ...... 996c0e418537acd1ac135363e5ac0]
@en